Found: 672
Select item for more details and to access through your institution.
The headache research priorities: Research goals from the American Headache Society and an international multistakeholder expert group.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 8, p. 912, doi. 10.1111/head.14797
- By:
- Publication type:
- Article
Plain Language Summary Publication: Characterizing neck pain during headache among people with migraine: Multicountry results from the Chronic Migraine Epidemiology and Outcomes – International (CaMEO‐I) cross‐sectional study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 8, p. 1070, doi. 10.1111/head.14786
- By:
- Publication type:
- Article
Machine learning identifies factors most associated with seeking medical care for migraine: Results of the OVERCOME (US) study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 8, p. 1027, doi. 10.1111/head.14729
- By:
- Publication type:
- Article
Standardizing Emergency Department–based Migraine Research: An Analysis of Commonly Used Clinical Trial Outcome Measures.
- Published in:
- Academic Emergency Medicine, 2010, v. 17, n. 1, p. 72, doi. 10.1111/j.1553-2712.2009.00587.x
- By:
- Publication type:
- Article
Clinical expression of LRRK2 G2019S mutations in the elderly.
- Published in:
- Movement Disorders, 2010, v. 25, n. 15, p. 2571, doi. 10.1002/mds.23330
- By:
- Publication type:
- Article
Validity of spiral analysis in early Parkinson's disease.
- Published in:
- Movement Disorders, 2008, v. 23, n. 4, p. 531, doi. 10.1002/mds.21874
- By:
- Publication type:
- Article
Elevated Blood Homocysteine Increases the Risk of Incident Motoric Cognitive Risk Syndrome: A Two-Cohort Study.
- Published in:
- Journals of Gerontology Series A: Biological Sciences & Medical Sciences, 2024, v. 79, n. 7, p. 1, doi. 10.1093/gerona/glae114
- By:
- Publication type:
- Article
"Cognitive" Criteria in Older Adults With Slow Gait Speed: Implications for Motoric Cognitive Risk Syndrome.
- Published in:
- Journals of Gerontology Series A: Biological Sciences & Medical Sciences, 2024, v. 79, n. 4, p. 1, doi. 10.1093/gerona/glae038
- By:
- Publication type:
- Article
APOE ε4 and the Influence of Sex, Age, Vascular Risk Factors, and Ethnicity on Cognitive Decline.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A Multi-study Coordinated Meta-analysis of Pulmonary Function and Cognition in Aging.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A Gray Matter Volume Covariance Network Associated with the Motoric Cognitive Risk Syndrome: A Multicohort MRI Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Association between renal function and cognitive ability domains in the Einstein aging study: a cross-sectional analysis.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Reliability and Validity of the Migraine Disability Assessment Scale among Migraine and Tension Type Headache in Iranian Patients.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Reliability and Validity of the Migraine Disability Assessment Scale among Migraine and Tension Type Headache in Iranian Patients.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/978064
- By:
- Publication type:
- Article
Cardiovascular disease risk exacerbates brain aging among Hispanic/Latino adults in the SOL-INCA-MRI Study.
- Published in:
- Frontiers in Aging Neuroscience, 2024, p. 01, doi. 10.3389/fnagi.2024.1390200
- By:
- Publication type:
- Article
Within-Person Across-Neuropsychological Test Variability and Incident Dementia.
- Published in:
- JAMA: Journal of the American Medical Association, 2008, v. 300, n. 7, p. 823, doi. 10.1001/jama.300.7.823
- By:
- Publication type:
- Article
Migraine and Cardiovascular Disease.
- Published in:
- 2006
- By:
- Publication type:
- Editorial
Is Migraine a Progressive Brain Disease?
- Published in:
- 2004
- By:
- Publication type:
- Editorial
Cerebral Hemodynamics in the Elderly.
- Published in:
- Journal of Ultrasound in Medicine, 2016, v. 35, n. 9, p. 1907, doi. 10.7863/ultra.15.10040
- By:
- Publication type:
- Article
Framing potential for adverse effects of repetitive subconcussive impacts in soccer in the context of athlete and non-athlete controls.
- Published in:
- Brain Imaging & Behavior, 2021, v. 15, n. 2, p. 882, doi. 10.1007/s11682-020-00297-4
- By:
- Publication type:
- Article
Detecting biological heterogeneity patterns in ADNI amnestic mild cognitive impairment based on volumetric MRI.
- Published in:
- Brain Imaging & Behavior, 2020, v. 14, n. 5, p. 1792, doi. 10.1007/s11682-019-00115-6
- By:
- Publication type:
- Article
Gray matter volume covariance patterns associated with gait speed in older adults: a multi-cohort MRI study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Hippocampal volume and cingulum bundle fractional anisotropy are independently associated with verbal memory in older adults.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Prevalence of incidental brain MRI findings of clinical relevance in a diverse Hispanic/Latino population.
- Published in:
- Journal of Neuroimaging, 2021, v. 31, n. 6, p. 1166, doi. 10.1111/jon.12910
- By:
- Publication type:
- Article
Subsets of a Large Cognitive Battery Better Power Clinical Trials on Early Stage Alzheimer's Disease.
- Published in:
- Neuroepidemiology, 2014, v. 43, n. 2, p. 131, doi. 10.1159/000365733
- By:
- Publication type:
- Article
Pain Intensity and Pain Interference in Older Adults: Role of Gender, Obesity and High-Sensitivity C-Reactive Protein.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Efficacy and Safety of Rimegepant 75 mg Oral Tablet, a CGRP Receptor Antagonist, for the Acute Treatment of Migraine: A Randomized, Double-Blind, Placebo-Controlled Trial.
- Published in:
- Journal of Pain Research, 2024, v. 17, p. 2431, doi. 10.2147/JPR.S453806
- By:
- Publication type:
- Article
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Tolerability, and Safety of Celecoxib Oral Solution (ELYXYB) in Acute Treatment of Episodic Migraine with or without Aura.
- Published in:
- Journal of Pain Research, 2021, v. 14, p. 2529, doi. 10.2147/JPR.S322292
- By:
- Publication type:
- Article
Acute Treatment of Migraine with Celecoxib Oral Solution: Results of a Randomized, Placebo-Controlled Clinical Trial.
- Published in:
- Journal of Pain Research, 2021, v. 14, p. 549, doi. 10.2147/JPR.S287571
- By:
- Publication type:
- Article
Association of a Functional Polymorphism in the Cholesteryl Ester Transfer Protein (CETP) Gene With Memory Decline and Incidence of Dementia.
- Published in:
- JAMA: Journal of the American Medical Association, 2010, v. 303, n. 2, p. 150, doi. 10.1001/jama.2009.1988
- By:
- Publication type:
- Article
Aging, encoding specificity, and memory change in the Double Memory Test.
- Published in:
- Journal of the International Neuropsychological Society, 1995, v. 1, n. 5, p. 483, doi. 10.1017/S1355617700000576
- By:
- Publication type:
- Article
Trajectories of frailty in aging: Prospective cohort study.
- Published in:
- PLoS ONE, 2021, v. 16, n. 7, p. 1, doi. 10.1371/journal.pone.0253976
- By:
- Publication type:
- Article
Situational prevention: Pharmacotherapy during periods of increased risk for migraine attacks.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 7, p. 859, doi. 10.1111/head.14775
- By:
- Publication type:
- Article
Characterizing neck pain during headache among people with migraine: Multicountry results from the Chronic Migraine Epidemiology and Outcomes – International (CaMEO‐I) cross‐sectional study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 7, p. 750, doi. 10.1111/head.14753
- By:
- Publication type:
- Article
Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 7, p. 838, doi. 10.1111/head.14743
- By:
- Publication type:
- Article
Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi‐country results from the CaMEO‐I study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 5, p. 469, doi. 10.1111/head.14721
- By:
- Publication type:
- Article
Prevalence and burden of migraine in the United States: A systematic review.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 5, p. 516, doi. 10.1111/head.14709
- By:
- Publication type:
- Article
A randomized, open‐label, 5‐period crossover study evaluating the pharmacokinetics and safety of a single dose of intranasal dihydroergotamine (DHE) powder (STS101), intramuscular DHE mesylate, and liquid nasal spray DHE in healthy adults.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 3, p. 266, doi. 10.1111/head.14685
- By:
- Publication type:
- Article
The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 2, p. 156, doi. 10.1111/head.14664
- By:
- Publication type:
- Article
Impact of monthly headache days on migraine‐related quality of life: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 10, p. 1448, doi. 10.1111/head.14629
- By:
- Publication type:
- Article
Evaluating therapeutic benefits of ubrogepant via latent class models: A post hoc exploratory analysis of the ACHIEVE I and ACHIEVE II trials.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 10, p. 1412, doi. 10.1111/head.14631
- By:
- Publication type:
- Article
Plasma calcitonin gene–related peptide and nerve growth factor as headache and pain biomarkers in recently deployed soldiers with and without a recent concussion.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 9, p. 1240, doi. 10.1111/head.14635
- By:
- Publication type:
- Article
Priority acute and preventive migraine treatment benefits: Results of the Migraine Clinical Outcome Assessment System (MiCOAS) qualitative study of people living with migraine.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 7, p. 953, doi. 10.1111/head.14521
- By:
- Publication type:
- Article
Migraine screening in English and Spanish.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 7, p. 843, doi. 10.1111/head.14520
- By:
- Publication type:
- Article
Long‐term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 6, p. 730, doi. 10.1111/head.14536
- By:
- Publication type:
- Article
Living in society, living with migraine: Editorial for the 2022 Members' Choice Award paper.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 6, p. 714, doi. 10.1111/head.14530
- By:
- Publication type:
- Article
Changes in migraine interictal burden following treatment with galcanezumab: Results from a phase III randomized, placebo‐controlled study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 5, p. 683, doi. 10.1111/head.14460
- By:
- Publication type:
- Article
Patient‐reported experiences with migraine‐related cognitive symptoms: Results of the MiCOAS qualitative study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 3, p. 441, doi. 10.1111/head.14484
- By:
- Publication type:
- Article
Predictors of treatment‐response to caffeine combination products, acetaminophen, acetylsalicylic acid (aspirin), and nonsteroidal anti‐inflammatory drugs in acute treatment of episodic migraine.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 3, p. 342, doi. 10.1111/head.14459
- By:
- Publication type:
- Article
Phase Ib, open‐label, fixed‐sequence, drug–drug interaction, safety, and tolerability study between atogepant and ubrogepant in participants with a history of migraine.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 3, p. 322, doi. 10.1111/head.14433
- By:
- Publication type:
- Article